Development of tumor-targeted therapy using measles virus-displayed antibody library

利用麻疹病毒展示抗体库开发肿瘤靶向治疗

基本信息

  • 批准号:
    22659227
  • 负责人:
  • 金额:
    $ 2.06万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
  • 财政年份:
    2010
  • 资助国家:
    日本
  • 起止时间:
    2010 至 2011
  • 项目状态:
    已结题

项目摘要

We have successfully developed a pseudoreceptor system which allows rescue and propagation of retargeted viruses displaying single chain antibody fragments(scFvs). Thus, receptor choice is not a significant limitation for targeting measles viruses and the use of single chain antibodies for targeting potentially allows us to redirect the virus against any chosen cellular receptor.In this study, we try to develop measles virus-displayed scFv library(virobody library) using the technology for identification of tumor-specific scFv. Human A549 lung, or BxPC-3 pancreatic carcinoma cells were infected with virobody library at an MOI of 0. 01 to 1, one hour later the cells were washed with Opti-MEM medium(Invitrogen) four times. 2 to 5 days after infection, propagated viruses were harvested by repeated freeze-thaw cycles from the GFP-positive infected cells. The biopanning was repeated several times, and finally the tumor-targeted measles virus was cloned from the GFP-positive infected cells. The cDNA encoding scFv from the viral RNA genome was amplified by RT-PCR for sequence analysis. However, the identified scFvs were not functional as a tumor-specific antibody. We have assumed that the diversity of measles virus-displayed scFv library is not sufficient enough to identify tumor-specific scFvs. To address this question, not traditional ligation method but Gateway[○! R] Technology-based cloning method(Invitrogen) was used for generation of plasmid library. Various kind of scFvs were incorporated into the C terminus of a receptor-blind H gene in a full-length cDNA clone of Edmonston measles virus. Furthermore, infectious scFv-displaying measles viruses were rescued from the full-length cDNA clones using helper vaccinia virus expressing T7 RNA polymerase. These modifications dramatically increased the diversity of measles virus-displayed scFv library.
我们已经成功地开发了一个伪受体系统,该系统允许拯救并宣传自动式病毒单链片段(SCFV)。通过该技术,我们尝试开发病毒引起的SCFV文库,以鉴定肿瘤特异性SCFV。 。 -PCR用于序列分析,确定的SCFV是肿瘤特异性抗体的功能这个问题不是传统的连接方法对接(○!麻疹病毒此外,使用表达T7 Na聚合酶的辅助病毒病毒从全长的克隆中发出感染性SCFV脱落的麻疹。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
マイクロRNAによって制御されるウイルスの開発とその応用
microRNA控制病毒的研制及其应用
  • DOI:
  • 发表时间:
    2010
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Sawada Y;Sugita K;Kabashima R;Hino R;Nakamura M;Koga C;Tokura Y;高橋昭久;中村貴史
  • 通讯作者:
    中村貴史
Highly Attenuated Vaccinia Virus as a Potential Oncolytic Agent for Cancer Virotherapy
高度减毒痘苗病毒作为癌症病毒治疗的潜在溶瘤剂
  • DOI:
  • 发表时间:
    2010
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Fusasaki T;Narita R;Hiura M;Abe S;Tabaru A;Hino R;Matsuyama A;Shimajiri S;Tokura Y;Sasaguri Y;Harada M;Nakamura T
  • 通讯作者:
    Nakamura T
MicroRNA Targeting of Oncolytic Viruses for cancer therapy
用于癌症治疗的溶瘤病毒的 MicroRNA 靶向
  • DOI:
  • 发表时间:
    2011
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Takafumi Nakamura.
  • 通讯作者:
    Takafumi Nakamura.
Highly attenuated vaccinia virus with microRNA-regulated oncolysis for cancer virotherapy
具有 microRNA 调节溶瘤作用的高度减毒痘苗病毒用于癌症病毒治疗
  • DOI:
  • 发表时间:
    2010
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Kiyokawa N;et al.;Nakamura T
  • 通讯作者:
    Nakamura T
MicroRNA-regulated oncolytic vaccinia virus not only enhances the oncolytic activity but also reduces the viral pathogenicity
MicroRNA调控的溶瘤痘苗病毒不仅增强溶瘤活性还降低病毒致病性
  • DOI:
  • 发表时间:
    2010
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Nakamura M;Sugita K;Tokura Y;大西武雄;Nakamura T
  • 通讯作者:
    Nakamura T
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NAKAMURA Takafumi其他文献

NAKAMURA Takafumi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NAKAMURA Takafumi', 18)}}的其他基金

Novel strategy of cancer virotherapy for radical cure of both primary and metastatic tumors
用于根治原发性和转移性肿瘤的癌症病毒治疗新策略
  • 批准号:
    19H03515
  • 财政年份:
    2019
  • 资助金额:
    $ 2.06万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
A novel oncolytic virotherapy for paclitaxel resistant ovarian cancer
一种治疗紫杉醇耐药性卵巢癌的新型溶瘤病毒疗法
  • 批准号:
    17K19597
  • 财政年份:
    2017
  • 资助金额:
    $ 2.06万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Tumor-targeted MAPK-dependent recombinant vaccinia virus for oncolytic virotherapy
用于溶瘤病毒治疗的肿瘤靶向 MAPK 依赖性重组牛痘病毒
  • 批准号:
    15H04310
  • 财政年份:
    2015
  • 资助金额:
    $ 2.06万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of tumor-targeted therapy using lentivirus-displayed antibody library
利用慢病毒展示抗体库开发肿瘤靶向治疗
  • 批准号:
    24650629
  • 财政年份:
    2012
  • 资助金额:
    $ 2.06万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
MicroRNA Targeting of Oncolytic Viruses for cancer therapy
用于癌症治疗的溶瘤病毒的 MicroRNA 靶向
  • 批准号:
    22680065
  • 财政年份:
    2010
  • 资助金额:
    $ 2.06万
  • 项目类别:
    Grant-in-Aid for Young Scientists (A)
The concepts of rule and responsibility based on "New Humeanism"
基于“新休谟主义”的规则与责任理念
  • 批准号:
    21720004
  • 财政年份:
    2009
  • 资助金额:
    $ 2.06万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Fundamental study in modern city at secondary education chance -Reproduction strategy of business layer where individual data was used-
利用中等教育机会进行现代城市的基础研究 -使用个人数据的业务层的再现策略-
  • 批准号:
    20530788
  • 财政年份:
    2008
  • 资助金额:
    $ 2.06万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of the new treatment strategy for cancer using the transgenic mice that induced the epithelial tumors
使用诱导上皮肿瘤的转基因小鼠开发新的癌症治疗策略
  • 批准号:
    19591927
  • 财政年份:
    2007
  • 资助金额:
    $ 2.06万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似国自然基金

基于自然人群队列评估口腔菌群在食管癌前病变/癌发病中的作用研究
  • 批准号:
    82304214
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
PDCD10通过CTGF促进巨噬细胞M2极化介导肝细胞癌免疫抑制的作用和机制研究
  • 批准号:
    82303186
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
STAG2与ATM合成致死靶向治疗食管癌的作用与机制探究
  • 批准号:
    82373190
  • 批准年份:
    2023
  • 资助金额:
    48 万元
  • 项目类别:
    面上项目
PRL-3磷酸酶上调抑癌基因P53导致结直肠癌细胞乳酸再利用的促癌机制
  • 批准号:
    82372656
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
基于血红素加氧酶-1的原位在体检测和靶向泛癌治疗研究
  • 批准号:
    22377029
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目

相似海外基金

Development of endoscopic surgery displaying tumor location and landmark navigated by artificial intelligence
通过人工智能导航显示肿瘤位置和标志的内窥镜手术的发展
  • 批准号:
    22H03977
  • 财政年份:
    2022
  • 资助金额:
    $ 2.06万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of cancer immunotherapy using hyperfusogenic receptor-retargeted HSV
使用超融合受体重靶向 HSV 开发癌症免疫疗法
  • 批准号:
    17H01578
  • 财政年份:
    2017
  • 资助金额:
    $ 2.06万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Development of newly immuno-viral therapy incorporated in tumor microenvironment theory for gastrointestinal cancer
结合肿瘤微环境理论开发新型免疫病毒疗法治疗胃肠道癌症
  • 批准号:
    19390341
  • 财政年份:
    2007
  • 资助金额:
    $ 2.06万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Telomerase specific oncolytic virotherapy to purge lymph node metastasis for minimizing invasiveness of gastrointestinal surgery
端粒酶特异性溶瘤病毒疗法可清除淋巴结转移,最大限度地减少胃肠道手术的侵入性
  • 批准号:
    19591543
  • 财政年份:
    2007
  • 资助金额:
    $ 2.06万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Eradication of HPV post surgical treatments, its correlation with specific types, type of surgeries, and the physical status
手术治疗后HPV的根除率及其与具体类型、手术类型和身体状况的相关性
  • 批准号:
    13671720
  • 财政年份:
    2001
  • 资助金额:
    $ 2.06万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了